UB Paderborn / Katalog / Suche / in CDI

Relative bioavailability and food effect study of an oral suspension of alectinib in healthy volunteers using venipuncture and capillary microsampling

Clinical and translational science, 2023-06, Vol.16 (6), p.1085-1096

2023

Volltextzugriff (PDF)

Bioanalysis of alectinib and metabolite M4 in human plasma, cross-validation and impact on PK assessment

Bioanalysis, 2016-07, Vol.8 (14), p.1465-1479

2016

Volltextzugriff (PDF)

Determination of carnitine and acylcarnitines in biological samples by capillary electrophoresis–mass spectrometry

Journal of chromatography. B, Biomedical sciences and applications, 1999-12, Vol.735 (2), p.171-188

1999

Volltextzugriff (PDF)

High-Throughput Bioanalytical LC/MS/MS Determination of Benzodiazepines in Human Urine: 1000 Samples per 12 Hours

Analytical chemistry (Washington), 1999-07, Vol.71 (13), p.2294-2300

1999

Volltextzugriff (PDF)

Model‐Based Drug–Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular Atrophy

Clinical pharmacology and therapeutics, 2021-12, Vol.110 (6), p.1547-1557

2021

Volltextzugriff (PDF)

Determination of Taspoglutide in Human and Animal Plasma Using Liquid Chromatography−Tandem Mass Spectrometry with Orthogonal Column-Switching

Analytical chemistry (Washington), 2009-05, Vol.81 (10), p.3705-3713

2009

Volltextzugriff (PDF)

Atmospheric pressure ionization time-of-flight mass spectrometry coupled with fast liquid chromatography for quantitation and accurate mass measurement of five pharmaceutical drugs in human plasma

Journal of mass spectrometry., 2000-03, Vol.35 (3), p.423-431

2000

Volltextzugriff (PDF)

A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier

British journal of clinical pharmacology, 2019-01, Vol.85 (1), p.181-193

2019

Volltextzugriff (PDF)

Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug–Drug Interactions in Children

Clinical pharmacokinetics, 2023-06, Vol.62 (6), p.891-904

2023

Volltextzugriff (PDF)

Bioanalytical aspects and challenges in supporting pediatric drug development

Bioanalysis, 2020-11, Vol.12 (21), p.1505-1508

2020

Volltextzugriff (PDF)

Dalcetrapib pharmacokinetics and metabolism in the cynomolgus monkey

Xenobiotica, 2011-05, Vol.41 (5), p.430-436

2011

Volltextzugriff (PDF)

Nonclinical cardiovascular safety assessment of thioridazine: Impact of autonomic tone, body temperature, and choice of species

Journal of pharmacological and toxicological methods, 2022-05, Vol.115, p.107167-107167, Article 107167

2022

Volltextzugriff (PDF)

Effect of mild or moderate hepatic impairment on the pharmacokinetics of risdiplam

British journal of clinical pharmacology, 2022-08, Vol.88 (8), p.3749-3759

2022

Volltextzugriff (PDF)

Addressing Today's Absorption, Distribution, Metabolism, and Excretion (ADME) Challenges in the Translation of In Vitro ADME Characteristics to Humans: A Case Study of the SMN2 mRNA Splicing Modifier Risdiplam

Drug metabolism and disposition, 2022-01, Vol.50 (1), p.65-75

2022

Volltextzugriff (PDF)

Inconsistent internal standard response in LC–MS/MS bioanalysis: an evaluation of case studies

Bioanalysis, 2019-09, Vol.11 (18), p.1657-1667

2019

Volltextzugriff (PDF)

Separation of ionic and neutral surfactants by capillary electrophoresis and high-performance liquid chromatography

Journal of Chromatography A, 1996-09, Vol.745 (1), p.281-292

1996

Volltextzugriff (PDF)

Separation of Nonionic Surfactants by Capillary Electrophoresis and High-Performance Liquid Chromatography

Analytical chemistry (Washington), 1998-05, Vol.70 (9), p.1885-1892

1998

Volltextzugriff (PDF)

Massenspektrometrische identifizierung und charakterisierung von posttranslationalen modifikationen bei pathologischen freien antikörperleichtketten

Heinig, Katja

2015

Volltextzugriff (PDF)

Ocular bioanalysis: challenges and advancements in recent years for these rare matrices

Bioanalysis, 2017-12, Vol.9 (24), p.1997-2014

2017

Volltextzugriff (PDF)

Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects

Xenobiotica, 2017-03, Vol.47 (3), p.217-229

2017

Volltextzugriff (PDF)

The oral splicing modifier RG7800 increases full length survival of motor neuron 2 mRNA and survival of motor neuron protein: Results from trials in healthy adults and patients with spinal muscular atrophy

Neuromuscular disorders : NMD, 2019-01, Vol.29 (1), p.21-29

2019

Volltextzugriff (PDF)

Sensitive determination of a drug candidate in dried blood spots using a TLC-MS interface integrated into a column-switching LC-MS/MS system

Bioanalysis, 2010-11, Vol.2 (11), p.1873-1882

2010

Volltextzugriff (PDF)

LC-MS/MS determination of alectinib and its major human metabolite M4 in human urine: prevention of nonspecific binding

Bioanalysis, 2017-03, Vol.9 (5), p.459-468

2017

Volltextzugriff (PDF)

What are the challenges of stability investigations and sample stabilization in regulated bioanalysis?

Bioanalysis, 2013-08, Vol.5 (15), p.1811-1814

2013

Volltextzugriff (PDF)

Stabilization of clinical samples collected for quantitative bioanalysis--a reflection from the European Bioanalysis Forum

Bioanalysis, 2015-01, Vol.7 (3), p.333-343

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Relative bioavailability and food effect study of an oral suspension of alectinib in healthy volunteers using venipuncture and capillary microsampling

Bioanalysis of alectinib and metabolite M4 in human plasma, cross-validation and impact on PK assessment

Determination of carnitine and acylcarnitines in biological samples by capillary electrophoresis–mass spectrometry

High-Throughput Bioanalytical LC/MS/MS Determination of Benzodiazepines in Human Urine: 1000 Samples per 12 Hours

Model‐Based Drug–Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular Atrophy

Determination of Taspoglutide in Human and Animal Plasma Using Liquid Chromatography−Tandem Mass Spectrometry with Orthogonal Column-Switching

Atmospheric pressure ionization time-of-flight mass spectrometry coupled with fast liquid chromatography for quantitation and accurate mass measurement of five pharmaceutical drugs in human plasma

A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier

Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug–Drug Interactions in Children

Bioanalytical aspects and challenges in supporting pediatric drug development

Dalcetrapib pharmacokinetics and metabolism in the cynomolgus monkey

Nonclinical cardiovascular safety assessment of thioridazine: Impact of autonomic tone, body temperature, and choice of species

Effect of mild or moderate hepatic impairment on the pharmacokinetics of risdiplam

Addressing Today's Absorption, Distribution, Metabolism, and Excretion (ADME) Challenges in the Translation of In Vitro ADME Characteristics to Humans: A Case Study of the SMN2 mRNA Splicing Modifier Risdiplam

Inconsistent internal standard response in LC–MS/MS bioanalysis: an evaluation of case studies

Separation of ionic and neutral surfactants by capillary electrophoresis and high-performance liquid chromatography

Separation of Nonionic Surfactants by Capillary Electrophoresis and High-Performance Liquid Chromatography

Massenspektrometrische identifizierung und charakterisierung von posttranslationalen modifikationen bei pathologischen freien antikörperleichtketten

Ocular bioanalysis: challenges and advancements in recent years for these rare matrices

Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects

The oral splicing modifier RG7800 increases full length survival of motor neuron 2 mRNA and survival of motor neuron protein: Results from trials in healthy adults and patients with spinal muscular atrophy

Sensitive determination of a drug candidate in dried blood spots using a TLC-MS interface integrated into a column-switching LC-MS/MS system

LC-MS/MS determination of alectinib and its major human metabolite M4 in human urine: prevention of nonspecific binding

What are the challenges of stability investigations and sample stabilization in regulated bioanalysis?

Stabilization of clinical samples collected for quantitative bioanalysis--a reflection from the European Bioanalysis Forum

Aktive Filter

Suchergebnisse filtern